Testing version — LOERadar is in active testing. Features and data may change.
ONCOVIN (VINCRISTINE SULFATE) | LOERadar
ONCOVIN
NDA
VINCRISTINE SULFATE | N014103 | ELI LILLY AND CO
3 strengths0 unique patents0 unique exclusivities
PTAB Proceedings
No IPR/PGR/CBM challenges found at the Patent Trial and Appeal Board
Hatch-Waxman Litigation
Para IV certification filed but no ANDA patent litigation cases (NOS 835) matched from PACER. Litigation may be pending or filed under a different caption.
Citizen Petitions
No FDA citizen petitions matched from Regulations.gov
Products (3)
Sort:
#001 — 1MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
RLD
0 patents0 exclusivities▴
INJECTABLE;INJECTION | Approved: Approved Prior to Jan 1, 1982
No patent or exclusivity listings for this strength.
#002 — 5MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
RLD
0 patents0 exclusivities▾
INJECTABLE;INJECTION | Approved: Approved Prior to Jan 1, 1982
#003 — 1MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**